While cellular LC3B and SQSTM1 levels serve as key autophagy markers, their regulation by different signaling pathways requires better understanding. Here, we report the mechanisms by which the Raf/MEK/ERK pathway regulates cellular LC3B and SQSTM1 levels. In different cell types, δRaf-1:ER-or B-Raf V600E -mediated MEK/ERK activation increased LC3B-I, LC3B-II, and SQSTM1/p62 levels, which was accompanied by increased BiP/GRP78 expression. Use of the autophagy inhibitors chloroquine and bafilomycin A1, or RNA interference of ATG7, suggested that these increases in LC3B and SQSTM1 levels were in part attributed to altered autophagic flux. However, intriguingly, these increases were also attributed to their increased expression. Upon Raf/MEK/ERK activation, mRNA levels of LC3B and SQSTM1 were also increased, and subsequent luciferase reporter analyses suggested that SQSTM1 upregulation was mediated at transcription level. Under this condition, transcription of BiP/GRP78 was also increased, which was necessary for Raf/MEK/ERK to regulate LC3B at the protein, but not mRNA, level. This suggests that BiP has a role in regulating autophagy machinery when Raf/MEK/ERK is activated. In conclusion, these results suggest that, under a Raf/MEK/ERK-activated condition, the steadystate cellular levels of LC3B and SQSTM1 can also be determined by their altered expression wherein BiP is utilized as an effector of the signaling.
Introduction
Autophagy is a constitutive lysosomal degradation pathway by which cells recycle cytoplasm and organelles to maintain cellular homeostasis. Under stress conditions, autophagy is upregulated to generate resources for the maintenance of essential cellular functions [1, 2] . Autophagy can affect cellular differentiation, development, and homeostasis, and its altered activity is often associated with several diseases, including cancer, which are mostly attributed to aberrant signal transduction [3] . Therefore, it is important to identify the signaling pathways that can affect cellular capacity for autophagy.
The Raf/MEK/extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathway is a threelayered kinase cascade, serving as a key signal transducer of receptor tyrosine kinases and the small GTPase, Ras [4] . The Ser/Thr kinase Raf (c-Raf-1, Raf-B or Raf-A) activates the dual-specificity kinases MEK1 and MEK2 which, in turn, sequentially phosphorylate Tyr and Thr in the activation loop of the ubiquitously expressed Ser/Thr kinases ERK1 and its homolog ERK2. Activated ERK1/2 mediates diverse biological processes by activating/ inactivating a wide variety of proteins, and different magnitudes of its activity can lead to distinct biological outputs [4] . The Raf/MEK/ERK pathway has pivotal roles in regulating cell survival, cell cycle progression and differentiation [5, 6] , and dysregulated Raf/MEK/ERK signaling is a central signature of many cancers [7] . Currently our understanding of the role of Raf/MEK/ERK pathway in the context of autophagy is limited.
BiP (HSPA5/GRP78), a member of the heat shock protein 72 (HSP72) family [8] , is a molecular chaperone that facilitates the folding and assembly of newly synthesized proteins in endoplasmic reticulum (ER) [9] and mediates the unfolded protein response by regulating the ER stress transducers, including PERK, IRE1, and ATF6 [10] . Upon onset of the ERassociated unfolded protein response, these molecules are liberated from BiP and become activated for cytoprotection. Therefore, BiP is characterized as a master regulator of ER stress. Recently, it has been discovered that autophagy is activated upon ER stress to facilitate cell survival [11, 12] , and that BiP has a critical role in this activation of autophagy [13] . Because ER stress is known to be triggered upon aberrant Raf/MEK/ERK activation [14, 15] , it may be possible that BiP plays a role for Raf/MEK/ERK in a context relevant to autophagy.
Microtubule-associated protein-1 light chain-3 (LC3), a mammalian homolog of yeast Atg8, and the LC3-binding protein, SQSTM1/p62, are the two key components in the formation of autophagosomes [16] . During autophagy, the cytoplasmic form of LC3 (LC3-I,18 kDa) is recruited to the autophagosome, where LC3-II (16 kDa) is generated by site-specific proteolysis and lipidation near to the C-terminus [17] . SQSTM1, on the other hand, binds LC3 and recruits proteins into autophagosomes for degradation [2] . Thus, increased LC3-II and decreased SQSTM1 levels indicate autophagic activity whereas SQSTM1 accumulation indicates defective autophagy. Nevertheless, it is possible that a change in LC3 and SQSTM1 levels indicates not only activity of the standard autophagy pathway but also other non-canonical mechanisms that can also affect their cellular levels.
In this study, we demonstrate that aberrant Raf/MEK/ERK activation is sufficient to increase cellular levels of LC3B-I and LC3B-II, and SQSTM1. Intriguingly, these increases in protein levels were also attributed to increased mRNA levels of LC3B and SQSTM1. Further, these changes were accompanied by BiP expression and our promoter luciferase reporter analysis indicated that Raf/MEK/ERK can upregulate transcription of BiP and SQSTM1. In addition, our evaluation of BiP function using RNA interference and gene overexpression suggests that BiP has a specific role in regulating cellular levels of LC3B protein, but not mRNA, under Raf/MEK/ERK-activated conditions. This study reveals previously unknown Raf/MEK/ERK-regulated signaling, which may affect cellular capacity for autophagy.
Materials and methods

Cell culture, generation of stable lines, and reagents
The human prostate cancer line, LNCaP (ATCC, CRL-1740), was maintained in phenol reddeficient RPMI 1640 (Invitrogen, 32404-014) supplemented with 10% fetal bovine serum (FBS), 100 U of penicillin and 100 μg of streptomycin per ml. The human embryonic kidney epithelial cell line, HEK293, was maintained in MEM (Invitrogen, 11095080) supplemented with 10% FBS, 100 U of penicillin and 100 μg of streptomycin per ml. The primary normal human fibroblasts BJ and E1A-immortalized IMR90 (IMR90E1A) were grown in DMEM supplemented with 10% FBS, 1% sodium pyruvate and 1% non-essential amino acids. The human melanoma lines, SK-MEL-28 (ATCC), SK-MEL-1 (ATCC), and RPMI-7951 (ATCC) were maintained in MEM (Invitrogen) supplemented with 10% FBS, 100 U of penicillin and 100 μg of streptomycin per ml. The human melanoma line, A375 (ATCC), was grown in DMEM (Invitrogen) supplemented with 10% FBS. The LNCaP line stably expressing ΔRaf-1:ER (LNCaP-Raf:ER) was previously described [18] . ΔRaf-1:ER was activated with 1 μM 4-hydroxytamoxifen (Sigma, H7904). Other chemicals used are the following: U0126 (Cell Signaling, 9903), MG-132 (Sigma, M7449), lactacystin (Sigma, L6785), bafilomycin A1 (Sigma, B1793), chloroquine (Sigma, C6628), and AZD6244 (Selleck Chemicals, 918505-84-7).
Recombinant lentiviral constructs and plasmids
The N-terminal HA-tagged BiP expression system constructed in the lentiviral pHAGE vector was previously described [19] . Constitutively active MEK2 in pHAGE (pHAGE-MEK2CA) was previously described [18] . pEGFP-LC3B was previously described [20] . pGRP78-promoter luciferase reporters were previously described [21] . SQSTM1-promoter luciferase reporter was previously described [22] .
Small hairpin RNA (shRNA) expression construct
Lentiviral shRNA expression systems were constructed using the pLL3.7 vector (ATCC, VRMC-39). pLL3.7-shBIP#1, pLL3.7-shBIP#2, and shBIP#3 target three different regions of human BIP mRNA, GTTGTGGCCACTAATGGAGA, ACCTTCGATGTGTCTCTTC, and GGAGCGCATTGATACTAGA. pLL3.7-shERK1 and pLL3.7-shERK2 were previously described [18] . The pLKO.1-shRNA vectors targeting ATG7 were purchased from Thermo Scientific (TRCN7586 and TRCN7587). Specific knockdown of target proteins was confirmed by Western blot analysis.
Viral infection
For lentivirus production, 293T cells were co-transfected with pHAGE, pLKO.1, or pLL3.7, and packaging vectors, as previously described [23, 24] . Viral supernatants were collected after 48-72 h and mixed with polybrene (Sigma, 107689) at 4-8 μg/ml before use. Viral titer was determined by scoring cells expressing GFP.
Reverse transcriptase polymerase chain reaction (RT-PCR) and quantitative real time PCR (qPCR)
Primers used for RT-PCR are CGGAGTCAACGGATTTGGTCGTAT and AGCCTTCTCCATGGTGGTGAAGAC (GAPDH), CCCGCGCGATGCCCTCAGACCGGCC and CTGGCTCAGAAGCCGAAGGTTTCCT (LC3A-v1), ATACAAGGGAAGTGGCTATC and TTACACTGACAATTTCATCC (LC3B), CTGCCCAGACTACGACTTGTGT and TCAACTTCAATGCCCAGAGG (SQSTM1), AAGCTCTCCCTGGTGGCCGCGATGCTGCTG and CTACAACTCATCTTTTTCTGCTGTATCCTC (BiP), AGCAACTCTGGATGGGATTG and CACTGCAGAGGTGTTTCCAA (ATG5), and ACCCAGAAGAAGCTGAACGA and AGACAGAGGGCAGGATAGCA (ATG7). Primers used for qPCR are CAACATGAGCGAGTTGGTCAAGA and ACTCACCATGCTGTGCTGGTTC (LC3A-v1), AGCAGCATCCAACCAAAATC and CTGTGTCCGTTCACCAACAG (LC3B), ATCGGAGGATCCGAGTGT and TGGCTGTGAGCTGCTCTT (SQSTM1), and TGCTGGCCTAAATGTTATG and TGGTGAGAAGAGACACATC (BiP). qPCR was performed by reverse transcription of 0.25 μg total RNA and subsequent polymerase chain reaction using the Mx3005P™ instrument (Stratagene, 401449) and Brilliant SYBR® Green QPCR Core Reagent Kit (Stratagene, 600546) according to the manufacturer's protocol. Thermocycling conditions were 10 min at 95 °C as first denaturation step, followed by 40 cycles at 95 °C for 30 s, 55 °C for 60 s and 72 °C for 30 s. For normalization, expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was measured.
Calculation of the gene copy number was carried out using comparative threshold cycle, as previously described [25] . Briefly, the mean threshold cycle (mC T ) was obtained from triplicate amplifications during the exponential phase of amplification. Then, mC T value of the reference gene was subtracted from mC T value of the target gene to obtain ΔC T . ΔΔC T values of each sample was calculated from corresponding C T values; where ΔΔC T = [mC T target (normal sample) -mC Treference (normal sample)] -[mC T target (test sample) -mC T reference (test sample)]. The calculated ΔΔC T was converted to ratio using the ratio formula (Ratio=2 T -ΔΔC ).
Luciferase reporter assay
Cells were transfected with different luciferase reporter constructs using Lipofectamine 2000 (Invitrogen, 11668). Transfected master cultures were then divided in triplicate into 24-well plates for further treatments, as described in the text. Cell lysates were analyzed using the Luciferase Assay System (Promega, E1910) according to the manufacturer's instructions. Reporter activity data were normalized for protein concentration.
Immunoblot analysis
Cells harvested at various times were lysed and analyzed using the BCA reagent to determine the protein concentration (Pierce, 23225), as we previously described [18] . 50-100 µg of protein was resolved by SDS-PAGE, transferred to a polyvinylidene difluoride membrane filter (Bio-Rad, 162-0177), and stained with Fast Green reagent (Thermo Fisher Scientific, BP123-10). Membrane filters were then blocked in 0.1 M Tris (pH 7.5)-0.9% NaCl-0.05% Tween 20 with 5% nonfat dry milk, and incubated with appropriate antibodies. Antibodies were diluted as follows: ATG7 ( 
Statistical analysis
Experiments were repeated at least three times. Statistical significance was determined by Student's t test for unpaired samples. P<0.05 was considered significant.
Results
Raf/MEK/ERK can increase LC3B and SQSTM1 levels in different cell types, which is accompanied by BiP expression
We determined the effect of Raf/MEK/ERK activation on LC3B, a major LC3 in the autophagosome [26] , and SQSTM1 in different cell types, including the human prostate cancer line LNCaP, immortalized human kidney epithelial cell line HEK293, primary cultured normal foreskin fibroblast BJ, and immortalized lung fibroblast IMR90E1A, which have been used as models to study the mechanisms underlying cellular responses to aberrant Raf/MEK/ERK activation [6, 18, 27] . To specifically control the pathway activity, we used the tamoxifen-regulated ΔRaf-1:ER, a CR3 catalytic domain of Raf-1 fused to hormone binding domain of the estrogen receptor [28] . When ΔRaf-1:ER was activated by 1 µM 4-hydroxytamoxifen in LNCaP and HEK293, these cells exhibited significantly increased LC3B and SQSTM1 protein levels within 48 h, along with increased ERK1/2 phosphorylation, which was accompanied by a significant increase in BiP levels (Fig. 1A) . Consistent with LNCaP and HEK293, BJ cells also exhibited similar responses, albeit to a lesser extent (Fig. 1A ). These changes were specific to Raf activation because 4-hydroxytamoxifen alone did not induce any similar effects (Fig. 1A) . Moreover, consistent with µRaf-1:ER, ectopically expressed oncogenic B-Raf V600E induced similar effects in IMR90E1A cells (Fig. 1B ). These data demonstrate that aberrant Raf activation can affect cellular levels of LC3B, SQSTM1, and BiP in different cell types.
Although MEK/ERK is the major effector of Raf, it has been reported that Raf can mediate MEK/ERK-independent signaling, e.g., cell death responses [29] . Therefore, we determined whether MEK/ERK is necessary for Raf to regulate LC3B, SQSTM1, and BiP. When ΔRaf-1:ER was activated in LNCaP cells pretreated with the MEK1/2-specific inhibitor, U0126, Raf-induced upregulation of LC3B, SQSTM1 and BiP were significantly reduced (Fig. 1C) . Consistent with this, shRNA-mediated knockdown of both ERK1 and ERK2 also effectively inhibited the effects of Raf activation (Fig. 1D) . Conversely, ectopic expression of a constitutively active mutant of MEK2 (ΔN4/S222D/S226D) induced similar effects as Raf activation (Fig. 1E) , indicating that MEK/ERK activation is necessary and sufficient for Raf to regulate LC3B, SQSTM1 and BiP.
To substantiate this observation, we also examined the effects of Raf/MEK/ERK inhibition on BiP, LC3 and SQSTM1 levels in B-Raf V600E mutated human melanoma lines, SK-MEL28, SK-MEL1, A375, and RPMI7951. When these cells were treated with AZD6244, a highly potent MEK1/2-specific inhibitor, BiP levels were substantially downregulated in SK-MEL28 and RPMI7951 cells, although not significantly affected in A375 and SK-MEL1 cells (Fig. 1F) . LC3B, especially LC3B-II, levels were also downregulated in SK-MEL1 cells while being mildly downregulated in SK-MEL28 and RPMI7951 cells (Fig. 1F) . In A375 cells, LC3B-II levels were slightly upregulated while LC3B-I levels being downregulated. SQSTM1 levels were substantially downregulated in SK-MEL28, SK-MEL1, and A375 cells, although not in RPMI7951 cells (Fig. 1F ). These data suggest that Raf/MEK/ERK activity can regulate BiP, LC3B and SQSTM1 levels in certain B-Raf V600E -mutated melanoma cells, further supporting the ability of Raf/MEK/ERK to regulate BiP, LC3 and SQSTM1.
Raf/MEK/ERK mediates temporal regulation of BiP, LC3B and SQSTM1 in a manner dependent upon its signaling intensity
Because the Raf/ME/ERK pathway is known to mediate different, even opposing, contexts of signaling transduction depending upon the magnitude and duration of its activation [4, 30] , we examined the effects of different magnitude and duration of Raf/MEK/ERK activation using ΔRaf-1:ER and different tamoxifen doses. As determined in LNCaP cells ( Fig. 2A) , induction of LC3, SQSTM1, and BiP upregulation was commensurate with the intensity of ERK1/2 phosphorylation, which suggest that strong activity of the Raf/MEK/ERK pathway is required to induce these effects.
When a time-course study was conducted using LNCaP and HEK293 cells, the highest induction of BiP expression was detected around 48 h after Raf activation in both cell lines, which was concurrent with the emergence of LC3B-II (Fig. 2B ). SQSTM1 increases occurred much earlier than expression of LC3B and BiP (Fig. 2B) . After 24 h, the rates of SQSTM1 upregulation were significantly decreased whereas BiP and LC3B upregulation became more significant (Fig. 2B ). These data indicate that Raf/MEK/ERK mediates a temporal regulation of BiP, LC3B, and SQSTM1, wherein regulation of SQSTM1 precedes other changes.
Raf-mediated increases in LC3B and SQSTM1 levels are augmented by autophagy inhibitors and ATG7 knockdown
The status of cellular autophagy can be more accurately determined by using the autophagy inhibitors or by modulating a key regulator of autophagy [31] . Chloroquine and bafilomycin A1 are the lysosomotropic agents which specifically block lysosomal degradation of autophagosomal contents [31] . When Raf was activated in cells in the presence of these chemicals at saturating doses, Raf-mediated increases in LC3B-II and SQSTM1 levels were strongly augmented ( Fig. 3A; Supplemental Fig. S1 ). We also investigated the effects of knockdown of autophagy-related gene ATG7. ATG7 is an E1 like enzyme that conjugates LC3-I to phosphatidylethanolamine to produce LC3-II in collaboration with ATG3 (E2-like enzymes) [32] . Therefore, in the absence of ATG7, accumulation of LC3-I is expected. We depleted ATG7 in LNCaP cells, using two different lentiviral shRNA constructs that specifically target different mRNA regions of ATG7 (shATG7 #1 and #2). As expected, ATG7 knockdown inhibited Raf-induced conversion of LC3B-I to LC3B-II and increased protein levels of LC3B-I and SQSTM1 without significantly affecting ERK1/2 phosphorylation (Fig. 3B ). These data suggested that Raf activation may be able to affect the autophagy flux.
Raf/MEK/ERK can also increase LC3B and SQSTM1 levels partly by upregulating their expression
To further understand the nature of Raf/MEK/ERK-mediated regulation of LC3B and SQSTM1, we measured their mRNA levels in LNCaP cells using RT-PCR and quantitative PCR analyses, which were conduced using different primer sets. We found that Raf activation could significantly increase mRNA levels of LC3B and SQSTM1 ( Fig. 4A ; top panel, RT-PCR; bottom, qPCR), while U0126 blocked Raf-induced increases in LC3B and SQSTM1 mRNA levels ( Fig. 4B ; left, RT-PCR; right, qPCR), suggesting that Raf/MEK/ ERK-induced increases in LC3B and SQSTM1 levels are also attributed to increased mRNA expression. Moreover, Raf activation mildly upregulated the activity of a luciferase reporter harboring 1.8 kb of human SQSTM1 promoter DNA (from -1781 to -7), which was consistently blocked by AZD6244 (Fig. 4C ). This suggests that Raf/MEK/ERK can upregulate SQSTM1 transcription.
In support of the possibility that Raf/MEK/ERK can upregulate LC3B and SQSTM1 expression, Raf-induced upregulation of LC3B and SQSTM1 protein levels was significantly abolished in the presence of cycloheximide, an inhibitor of protein synthesis (Fig. 4D) . Moreover, their upregulation by Raf was augmented in the presence of the proteasome inhibitors MG132 and lactacystin (Fig. 4E) . Of note, contrary to the effect of autophagy inhibitors to increase LC3B-II levels (Fig. 3A) , the proteasome inhibitors increased mainly LC3B-I levels (Fig. 4E) , suggesting that the proteasome may also regulate the levels of unprocessed LC3B. These data demonstrate that Raf/MEK/ERK can regulate LC3B and SQSTM1 levels via non-canonical mechanisms other than autophagy.
While LC3B has been known as the major LC3 in the autophagosome, a recent study demonstrated that the other LC3 family member LC3A-vareint1 can also mediate autophagosome formation as efficiently as LC3B [26] . Contrary to LC3B regulation, Raf activation significantly decreased LC3A-vareint1 mRNA levels (Fig. 4A) . However, Raf activation did not affect mRNA levels of the two key essential autophagy regulators, ATG5 and ATG7, whose transcriptional upregulation is required for prolonged autophagy [31] (Fig. 4A ). These data suggest that Raf/MEK/ERK can selectively and differentially regulate the expression of certain autophagy machinery.
Raf/MEK/ERK activation upregulates BiP expression transcriptionally
Along with the changes in LC3B and SQSTM1 mRNA levels, Raf activation highly upregulated BiP mRNA levels (Fig. 4A ), although this effect was blocked by U0126 (Fig.  4B) . However, in contrast, Raf activation did not significantly affect mRNA levels of the two major HSP70 family molecular chaperones, HSP72 (heat-inducible) and HSC70 (constitutively expressed), or HSP60 (Fig. 4A) , suggesting a specific requirement for BiP under Raf-activated conditions. Because BiP is known as a master regulator of ER stress response, we also examined whether Raf activation alters expression or splicing of the unfolded protein response-specific transcription factor, X-box binding protein 1 (XBP1), which indicates the onset of ER stress [10] . Raf activation did not upregulate XBP1 expression or splicing in LNCaP cells (Fig. 4A ). Subsequently, we analyzed phosphorylation of eukaryotic translation initiator factor 2α (eIF2α) and expression of the pro-apoptotic transcription factor C/EBP-homologous protein (CHOP/GADD153), which also indicate ER stress [10] . In LNCaP, HEK293, and BJ cells, activation of ΔRaf-1:ER did not significantly increase eIF2α phosphorylation (Fig. 1A) , although B-Raf V600E induced eIF2α phosphorylation in IMR90E1A cells (Fig. 1B) . Under these Raf-activated conditions, CHOP expression was induced only in HEK293 cells (Fig. 1A) . These data therefore indicate that BiP expression is more closely correlated with the changes in LC3B and SQSTM1 than the changes in ER stress markers when Raf/MEK/ERK is activated.
To understand the mechanisms underlying Raf/MEK/ERK-induced BiP expression, we investigated whether Raf activation could upregulate the activity of the luciferase reporters containing BiP promoter DNA. The BiP promoter reporters, pGRP78 (-367)-luc and pGRP78 (-169)-luc were previously used to identify the location of ER-stress response elements within the -169 region from the transcriptional initiation site [21] . We found that pGRP78(-367)-luc expressed higher basal and Raf-induced luciferase activity than pGRP78(-169)-luc when compared to the empty control vector, pGL2 (Fig. 4F) . Further, U0126 blocked Raf-induction of pGRP78(-367)-luc activity, indicating that Raf/MEK/ERK can upregulate BiP at transcription level (Fig. 4F) . Of note, despite their different activities, both reporters showed similar rates of fold induction in response to Raf activation, and this was contrasted to their responses to the ER stress inducer tunicamycin, which increased pGRP78(-169)-luc activity higher than pGRP(-367)-luc activity (Fig. 4G) . These different responses suggest that Raf/MEK/ERK may regulate BiP transcription via a mechanism different from the one regulated by ER stress.
Of note, contrary to the augmenting effects of chloroquine, bafilomycin A1, and ATG7 knockdown on Raf-induced BiP upregulation ( Fig. 3A and B) , the proteasome inhibitors did not significantly affect BiP induction by Raf (Fig. 4E) . Therefore, BiP levels under Raf-activated conditions may be determined by a balance between increased transcription and autophagic degradation.
BiP is necessary for Raf/MEK/ERK to regulate LC3B at protein levels, but not at mRNA levels
To determine the role of BiP in Raf-mediated regulation of LC3 and SQSTM1, we depleted BiP in LNCaP cells, using three different lentiviral shRNA constructs that specifically target different mRNA regions of BiP (shBiP #1, #2, and #3). All these constructs substantially abrogated both Raf-induced BiP expression and increases in LC3B-I and LC3B-II protein levels, indicating that BiP is required for Raf-mediated LC3B regulation (Fig. 5A for day 2 effects; Supplemental Fig. S2 for day 1 effects) . Nevertheless, BiP depletion did not significantly affect Raf-mediated regulation of LC3B mRNA levels ( Fig. 5B ; left panel, RT-PCR; right, qPCR), indicating that BiP is specifically required for Raf to regulate LC3B at protein levels.
Conversely, overexpression of BiP (evaluated at three different expression levels) markedly increased the level of Raf-induced upregulation of LC3B-I, but not LC3B-II in LNCaP cells (Fig. 5C ), without significantly affecting Raf-regulated LC3B mRNA expression ( Fig. 5D ; top panel, RT-PCR; bottom, qPCR) or autophagic flux under Raf-activated condition, as determined by using chloroquine (Supplemental Fig. S3 ). Of note, BiP overexpression by itself was not sufficient to increase LC3B-I levels, indicating that BiP may have a role specific to Raf/MEK/ERK activation. Importantly, BiP knockdown or overexpression did not affect ERK1/2 phosphorylation ( Fig. 5A and C) , indicating that the BiP effects were not due to altered Raf/MEK/ERK activity in cells but were mediated at a downstream level of the pathway signaling. These data suggests that BiP comprises a downstream pathway for Raf/MEK/ERK to regulate LC3B protein, although Raf/MEK/ERK regulates LC3 mRNA levels independently of BiP (depicted in Fig. 6 ).
Interestingly, both BiP knockdown and overexpression conditions further increased SQSTM1 protein levels in Raf-activated cells but did not affect its basal levels in the control cells ( Fig. 5A and C) . In contrast, Raf-mediated upregulation of SQSTM1 mRNA levels was not affected under any of these conditions ( Fig. 5B and D) . Therefore, either the absence of BiP or surplus of BiP may result in increased accumulation of SQSTM1 in Raf-activated cells. It is possible that these increases in SQSTM1 protein levels are due to limited LC3B supply under the BiP-depleted condition and due to inefficient processing of LC3B-I to LC3B-II under BiP-overexpressed condition.
Lastly, sustained Raf/MEK/ERK activation can paradoxically induce growth inhibition in different cell types, which is currently recognized as an anti-oncogenic mechanism in the face of aberrant Raf/MEK/ERK signal [33, 34] . We previously reported that Raf/MEK/ERK can induce similar responses in LNCaP cells [18, 19, 27] . Therefore, we evaluated the effect of ATG7 knockdown or BiP knockdown on Raf-induced growth inhibition. In LNCaP cells, depletion of ATG7 or BiP neither significantly affected Raf-induced cell cycle arrest in G0/G1 phase nor altered apoptotic index (Supplemental Figs. S4 and S5 ), suggesting that regulation of BiP and autophagy machinery is not indispensable for Raf/MEK/ERK to mediate growth inhibitory signaling.
Discussion
Our present study demonstrate that aberrant Raf/MEK/ERK activation is sufficient to induce signals that trigger an alteration in LC3B and SQSTM1 levels in a similar pattern indicating autophagy. Indeed, the effects of autophagy inhibitors and ATG7 knockdown suggest that Raf/MEK/ERK may be able to alter autophagic activity in cells. However, other data in this report suggest that Raf/MEK/ERK-induced changes in these autophagy markers are also attributed to other mechanisms. Of particular interest, Raf/MEK/ERK activation led to upregulation of LC3B and SQSTM1 at mRNA levels, and the increases in SQSTM1 mRNA levels were due to increased transcription. These results suggest that, under a Raf/MEK/ ERK-activated condition, the net steady-state levels of LC3B and SQSTM1 can be determined by multiple mechanisms including a non-canonical regulation of the autophagic machinery at an expression level (Fig. 6) . In support of the complexity in SQSTM1 regulation, it has recently been reported that not only autophagic degradation but also increased transcription can affect its net steady-state levels under a prolonged starvation condition [35] . A cautious interpretation of changes in LC3B and SQSTM1 levels is therefore required when studying the effect of the Raf/MEK/ERK pathway on autophagy.
Intriguingly, Raf/MEK/ERK activation also led to upregulation of the ER chaperone, BiP, along with LC3B and SQSTM1, and this addresses a mechanism by which Raf/MEK/ERK regulates LC3B processing. BiP appears to have a specific role for LC3B regulation in response to Raf/MEK/ERK activation because BiP expression was necessary for Rafinduced LC3B processing. LC3B is expressed as pro-LC3B, which is cleaved into LC3B-I by ATG4. LC3B-I is conjugated with phosphatidylethanolamine for its conversion into LC3B-II, a step mediated by ATG5 and ATG7. LC3B-II is then utilized for the formation of autophagosome [2] . ER is the reservoir of Ca 2+ and its release can activate calpain which inactivates ATG5 via proteolysis and, subsequently, inhibits LC3B processing [36] . Since BiP is the ER chaperone, these events may potentially be related. Indeed, under Raf/MEK/ ERK-activated conditions, BiP overexpression was associated with LC3B-I accumulation while BiP knockdown was associated with depletion of both intermediates of LC3B. Therefore, BiP may affect LC3B processing via ER activity although it may also regulate additional mechanisms, e.g., LC3B translation and/or protein stability. Intriguingly, BiP did not affect Raf-regulated LC3B mRNA levels in this study, although it was reported that ER stress can upregulate LC3B transcription via the PERK/ATF4 cascade, a key effector of BiP in mediating ER stress [37] . Moreover, Raf-induced LC3B processing was not strongly correlated with any obvious changes of ER stress markers other than BiP. Therefore, ER stress may not be necessary for aberrant Raf/MEK/ERK activity to induce LC3B processing, and the primary reason for Raf/MEK/ERK to induce BiP may be mainly to regulate LC3B. In support of this, our promoter reporter analysis suggests that Raf/MEK/ERK upregulates BiP transcription via a responsive element(s) different from those regulated by ER stress. Taken all, BiP function for Raf/MEK/ERK-mediated LC3B regulation is not entirely consistent with its role for ER stress-induced autophagy. Indeed, recent studies have demonstrated that BiP has additional functions in different subcellular locations other than ER [38, 39] . This possibility needs to be explored in our future study.
Our time-course data that SQSTM1 upregulation preceded the increases in LC3B and BiP may suggest a potential scenario in which these changes are important in the context of Raf/MEK/ERK signaling. A recent study has reported that, in addition to autophagosome formation, SQSTM1 facilitates nutrient sensing by serving as an integral scaffold of the mTORC1 complex required for activation of S6K1 and 4EBP1 [40] . The requirement of SQSTM1 for K-Ras tumorigenesis has also been demonstrated in a mouse lung tumor model [41] . Given these, it is conceivable that increased SQSTM1 expression may be due to cellular recognition of aberrant Raf/MEK/ERK activity as a mitogenic signal while dysregulation of this process may cause a metabolic stress, which induces BiP expression. Given that BiP confers stress tolerance in different cell types, including LNCaP cells [42] , and that autophagy generates resources for cell survival under stress conditions [1, 2] , it is conceivable that cells may attempt to resist stress by increasing autophagy partly via BiP upregulation under aberrant Raf/MEK/ERK activation conditions. Of note, it has been reported that ERK1/2-mediated autophagy induction is a mechanism underlying the development of cisplatin resistance of ovarian cancer [43] . Our findings may have potential significance in this context, providing an insight into the possible mechanisms by which ERK1/2 regulates autophagy. Future study is thus required to determine whether ERK1/2 can mediate similar effects on BiP, LC3 and SQSTM1 in cisplatin-resistant tumors.
It has been reported that oncogenic Ras requires MEK/ERK activation to induce autophagy [44, 45] . In this context, our results may provide an insight into the mechanism by which the Ras/Raf pathway regulates autophagy effectors. It appears that although Ras and Raf can commonly increase LC3B processing and expression, these two signal transducers affect autophagy effectors differently. For example, contrary to the Raf effects observed in this study, Ras activation decreased SQSTM1 protein levels [44] , while increasing ATG7 mRNA levels in human diploid fibroblast cells [45] . Indeed, although aberrant Ras or Raf activation triggers largely similar physiological effects, many of these effects are mediated via different mechanisms because Ras can activate additional pathways other than Raf/MEK/ERK, including the PI3-kinase/AKT and RalGDS pathways [46] . It is therefore conceivable that Raf/MEK/ERK alone may not be able to mediate balanced autophagy while Ras does so by activating additional pathways. In support of this notion, additional alterations of different signaling pathways are often detected in B-Raf V600E transformed tumors [47, 48] .
Our current study identifies BiP as a novel inducible effector of Raf/MEK/ERK. Considering that oncogenic Raf, such as B-Raf V600E , is often detected in different tumor types [7] , i.e., melanoma (≥ 70%), papillary thyroid cancer (≥ 50%), and colon cancer (≥ 10%), it is warranted to investigate BiP expression in these cancers in association with any autophagic alteration. In summary, our study demonstrates that (i) aberrant Raf/MEK/ERK activation is sufficient to increase not only LC3B processing and SQSTM1 accumulation but also their expression and (ii) Raf/MEK/ ERK induces BiP expression to regulate LC3B at protein levels. This study reveals novel Raf/MEK/ERK signaling, which may operate in a context relevant to autophagy. A model for Raf/EMK/ERK-mediated regulation of LC3 and SQSTM1. Raf/MEK/ERK activation is sufficient to induce alterations in LC3B and SQSTM1 levels, which is similar to the typical patterns indicating autophagy. Nonetheless, our results suggest that the net steady-state levels of LC3B and SQSTM1 under a Raf/MEK/ERK-activated condition are determined by not only the standard autophagic pathway but also by a regulation at mRNA levels and by an involvement of BiP. This signaling may be important in determining cellular capacity for autophagy under a Raf/MEK/ERK-activated condition.
